Skip to main content
. 2018 Sep 7;9(10):1698–1707. doi: 10.1039/c8md00257f

Table 3. The anti-MRSA selectivity versus antiproliferative (IC50) activity against RAW 264.7, MCF-7 and SF-268 cells.

RAW 264.7 MCF-7 SF-268
IC50 (μg mL–1) 5.6 ± 0.42 9.98 ± 1.08 10.15 ± 0.98
Selectivity ratio a 22.4 39.9 40.6

aSelectivity ratio = IC50/MIC against MRSA (JCSC 4788).